Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

Fahrleitner, A; Lauermann, T; Schreiber, B; Lewitschnig, S; Leb, G; Obermayer-Pietsch, B; Dobnig, H; Klima, G.
Intravenous ibandronate 1 mg every three months is an effective and well tolerated treatment option in patients with osteoporosis
OSTEOPOROSIS INT 2002 13: P42-P42.
Web of Science

 

Authors Med Uni Graz:
Dobnig Harald
Fahrleitner-Pammer Astrid
Obermayer-Pietsch Barbara
Altmetrics:


© Med Uni GrazImprint